共 49 条
[11]
Anastassiades T.P.(2003)EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 62 1145-91
[12]
Herrero-Beaumont G.(2005)Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses Arthritis Rheum 52 181-30
[13]
Ivorra J.A.R.(1998)Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo Osteoarthritis Cartilage 6 25-91
[14]
Del Carmen Trabado M.(1996)Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis J Rheumatol 23 1385-86
[15]
Fassbender H.M.(2005)Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial Arthritis Rheum 52 779-76
[16]
Bach G.L.(2004)Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo Osteoarthritis Cartilage 12 269-83
[17]
Haase W.(2007)Risk assessment for glucosamine and chondroitin sulfate Regul Toxicol Pharmacol 47 78-undefined
[18]
Qiu G.X.(undefined)undefined undefined undefined undefined-undefined
[19]
Gao S.N.(undefined)undefined undefined undefined undefined-undefined
[20]
Giacovelli G.(undefined)undefined undefined undefined undefined-undefined